Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
The oxidative phosphorylation inhibitor, atovaquone, upregulates PD-L1 via activation of the ATM/ATR DNA damage response pathway.
Journal: Research square
Published: May 07, 2026
Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppression.
Journal: Cellular and molecular life sciences : CMLS
Published: January 02, 2026
Synthesis of mRNA lipid nanoparticles for engineering GD2 CAR T and CAR NK cells against neuroblastoma.
Journal: bioRxiv : the preprint server for biology
Published: December 25, 2025
Standardized Isolation and Cytokine Priming of Murine Bone Marrow-Derived Mesenchymal Stromal Cells for Enhanced Immunomodulation.
Journal: Journal of visualized experiments : JoVE
Published: December 22, 2025
Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models.
Journal: Science advances
Published: December 05, 2025
IFNγ and TNFα optimize salivary gland mesenchymal stromal cells: an alternative to marrow- and adipose-MSCs for radiation xerostomia.
Journal: Regenerative therapy
Published: September 02, 2025
Regulatory B cell CCL3 competency promotes disease resolution and oligodendrogenesis in experimental autoimmune encephalomyelitis.
Journal: Communications biology
Published: April 29, 2025
A Phase I Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against BK-Virus in Adult Kidney Transplant Recipients.
Journal: Journal of medical virology
Published: January 27, 2025
Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use.
Journal: Cell stem cell
Published: January 22, 2025
Last Updated: 09/26/2026